ImmuCell Corporation Deferred Revenue
ImmuCell Corporation (ICCC) had Deferred Revenue of $24.10 thousand as of 2018-09-30, per its 10-Q filed 2018-11-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2019-03-22
- 2018-09-30: Deferred Revenue, Current $24.10K.
- 2018-06-30: Deferred Revenue, Current $24.10K.
- 2018-03-31: Deferred Revenue, Current $24.10K.
- 2017-12-31: Deferred Revenue, Current $24.10K.
| Period end | Deferred Revenue, Current |
|---|---|
| 2018-09-30 | $24.10K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $24.10K 10-Q · filed 2018-08-13 |
| 2018-03-31 | $24.10K 10-Q · filed 2018-05-14 |
| 2017-12-31 | $24.10K 10-K · filed 2019-03-22 |
| 2016-12-31 | $33.86K 10-K · filed 2018-03-29 |
| 2016-09-30 | $33.86K 10-Q · filed 2016-11-10 |
| 2015-12-31 | $0.00 10-Q · filed 2016-11-10 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-12 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-13 |
| 2015-03-31 | $6.69K 10-Q · filed 2015-05-12 |
| 2014-12-31 | $6.69K 10-K · filed 2016-03-25 |
| 2014-09-30 | $6.69K 10-Q · filed 2014-11-12 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-26 |
| 2013-06-30 | $250.00K 10-Q · filed 2013-08-13 |
| 2012-12-31 | $0.00 10-Q · filed 2013-08-13 |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-13 |
| 2012-06-30 | $0.00 10-Q/A · filed 2012-09-07 |
| 2012-03-31 | $8.25K 10-Q · filed 2012-05-14 |
| 2011-12-31 | $8.25K 10-K · filed 2013-03-28 |
| 2011-09-30 | $8.25K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $8.25K 10-Q · filed 2011-08-15 |
| 2010-12-31 | $0.00 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |